The Food and Drug Administration approved Eli Lilly’s weight-loss drug Zepbound on Dec. 27 to treat sleep apnea, a common but ...
Tryngolza (olezarsen) has been approved by the U.S. Food and Drug Administration as an adjunct to diet to reduce ...
The first medication for obstructive sleep apnea has been approved by the US Food and Drug Administration (FDA).
This may start to bring down the cost of brand-name competitors—here's who might get access, and one major difference from ...
The US Food and Drug Administration approved a generic once-daily injectable version of the glucagon-like peptide-1 receptor ...
“Today’s approval marks the first drug treatment option for certain patients with obstructive sleep apnea,” said Sally Seymour, M.D., director of the Division of Pulmonology, Allergy, and Critical ...
20, the FDA announced that the agency has approved Eli Lilly's Zepbound ... in adults with obesity. The drug is to be paired with a reduced-calorie diet and increased physical activity, the ...
FDA has approved the first prescription drug, Zepbound, for treating moderate to severe obstructive sleep apnea (OSA) in ...
The drugs were first approved to treat type 2 diabetes – and that's what the FDA said daily injections of liraglutide could ...
The U.S. Food and Drug Administration (FDA) has approved the first prescription medication specifically for treating ...